SCHEMBL7793406

SCHEMBL7793406

CS(=O)(=O)NC(CSSCC(NS(C)(=O)=O)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
CA1 P00915 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
CA9 Q16790 1/20 0.44
ANPEP P15144 1/20 0.44
MMP8 P22894 4/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
CA5A P35218 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7803203 0.88 POLB (0.51) POLBCA1KMT2ACYP2D6CYP2C9
SCHEMBL13073722 0.86 KMT2A (0.53) POLBKMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL7800969 0.86 MMP2 (0.55) POLBCA1CYP2C9CYP2C19CA2
SCHEMBL7793404 0.86 F10 (0.48) POLBCA1KMT2ACYP2D6CYP2C9
SCHEMBL7793421 0.82 POLB (0.43) POLBCA1KMT2ACYP2D6CYP2C9
SCHEMBL7793435 0.81 CA12 (0.52) POLBCA1KMT2ACYP2D6CYP2C9
SCHEMBL27744298 0.80 POLB (0.45) POLBCA1KMT2ACYP2D6CYP2C9
SCHEMBL7799262 0.79 POLB (0.52) POLBKMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL7798914 0.78 POLB (0.48) POLBKMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL7793390 0.77 KMT2A (0.57) KMT2ACA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed